{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:54:51Z","timestamp":1789786491073,"version":"4.0.1"},"reference-count":39,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2016,5,11]],"date-time":"2016-05-11T00:00:00Z","timestamp":1462924800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2016,10]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>\n                      Estimates of high blood pressure (\n                      <jats:styled-content style=\"fixed-case\">BP<\/jats:styled-content>\n                      ) incidence in children with congenital adrenal hyperplasia (\n                      <jats:styled-content style=\"fixed-case\">CAH<\/jats:styled-content>\n                      ) vary widely; risk factors are poorly understood. We estimated incidence of hypertension by\n                      <jats:styled-content style=\"fixed-case\">CAH<\/jats:styled-content>\n                      subtype and sex, and assessed its association with body mass index, hydrocortisone and fludrocortisone.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Longitudinal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients<\/jats:title>\n                    <jats:p>\n                      Chart review of 180 paediatric\n                      <jats:styled-content style=\"fixed-case\">CAH<\/jats:styled-content>\n                      patients (120 salt wasting; 60 simple virilizing; 93 females) seen from 1970 to 2013.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements<\/jats:title>\n                    <jats:p>\n                      High\n                      <jats:styled-content style=\"fixed-case\">BP<\/jats:styled-content>\n                      was diagnosed by diastolic or systolic blood pressure measurement \u226595th percentile for age, sex and height; hypertension was diagnosed with high\n                      <jats:styled-content style=\"fixed-case\">BP<\/jats:styled-content>\n                      on at least three clinic visits.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Children with classic\n                      <jats:styled-content style=\"fixed-case\">CAH<\/jats:styled-content>\n                      who received fludrocortisone had a significantly higher rate of hypertension (55%\n                      <jats:italic>vs<\/jats:italic>\n                      31%) than those who did not. Hypertension incidence was higher in salt\u2010wasting\n                      <jats:styled-content style=\"fixed-case\">CAH<\/jats:styled-content>\n                      (58%) than in simple\u2010virilizing\n                      <jats:styled-content style=\"fixed-case\">CAH<\/jats:styled-content>\n                      (35%). Hypertension first occurred before age 5 years in 91% of salt\u2010wasting males and 50% of cases in salt\u2010wasting females; most simple\u2010virilizing cases occurred during ages 10\u201318 years. Rates of hypertension were higher in children who had three or more measurements with 17\u2010\n                      <jats:styled-content style=\"fixed-case\">OHP<\/jats:styled-content>\n                      &lt; 400 ng\/dl (12\u00b712 nmol\/l), and this difference was significant in salt\u2010wasting males. Children on fludrocortisone who had three or more readings of 17\u2010\n                      <jats:styled-content style=\"fixed-case\">OHP<\/jats:styled-content>\n                      &lt; 400 ng\/dl (12\u00b712 nmol\/l) had a significantly higher rate of hypertension than those who did not. Hydrocortisone dose was not associated with hypertension.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Children with\n                      <jats:styled-content style=\"fixed-case\">CAH<\/jats:styled-content>\n                      are at higher risk for hypertension than the general paediatric population, and incidence differs by sex and\n                      <jats:styled-content style=\"fixed-case\">CAH<\/jats:styled-content>\n                      subtype. Hypertension was higher in children on fludrocortisone and who were oversuppressed.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/cen.13086","type":"journal-article","created":{"date-parts":[[2016,4,22]],"date-time":"2016-04-22T19:11:54Z","timestamp":1461352314000},"page":"528-534","source":"Crossref","is-referenced-by-count":45,"title":["Hypertension in children with congenital adrenal hyperplasia"],"prefix":"10.1111","volume":"85","author":[{"given":"Nadia","family":"Maccabee\u2010Ryaboy","sequence":"first","affiliation":[{"name":"University of Minnesota Masonic Children's Hospital Minneapolis MN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Thomas","sequence":"additional","affiliation":[{"name":"Division of Biostatistics School of Public Health University of Minnesota Minneapolis MN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Kyllo","sequence":"additional","affiliation":[{"name":"Children's Hospitals of Minnesota Minneapolis MN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Lteif","sequence":"additional","affiliation":[{"name":"The Mayo Clinic College of Medicine Rochester MN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Petryk","sequence":"additional","affiliation":[{"name":"University of Minnesota Masonic Children's Hospital Minneapolis MN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Gonzalez\u2010Bolanos","sequence":"additional","affiliation":[{"name":"University of Minnesota Masonic Children's Hospital Minneapolis MN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C","family":"Hindmarsh","sequence":"additional","affiliation":[{"name":"Institute of Child Health University College London London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyriakie","family":"Sarafoglou","sequence":"additional","affiliation":[{"name":"University of Minnesota Masonic Children's Hospital Minneapolis MN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,5,11]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2631"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.77.2.458"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.76.6.1505"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1711"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2009.03587.x"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2014.01.011"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/1687-9856-2009-383610"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1515\/JPEM.2004.17.8.1089"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-2102"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2003.01757.x"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12265"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1069"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.102995"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.114.S2.555"},{"key":"e_1_2_8_16_1","volume-title":"Drug Facts and Comparisons","author":"Wolters Kluwer Health","year":"1997"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.78.2.241"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2008.10.010"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1159\/000179303"},{"key":"e_1_2_8_20_1","unstructured":"Centers for Disease Control and Prevention(2014)A SAS Program for the 2000 CDC Growth Charts (ages 0 to <20 y).http:\/\/www.cdc.gov\/nccdphp\/dnpao\/growthcharts\/resources\/sas.htm."},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2014.11.027"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.111.1.61"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.17.2277"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199806043382302"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.113.3.475"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.8.874"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpv087"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12498"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(01)00527-2"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000172945.06681.a4"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1159\/000308891"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2011.01694.x"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2009.01274.x"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12045"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1995.tb02928.x"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2004.02035.x"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1926"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-006-0005-4"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2011.04309.x"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1805"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcen.13086","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcen.13086","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cen.13086","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T12:08:52Z","timestamp":1695557332000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cen.13086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,11]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["10.1111\/cen.13086"],"URL":"https:\/\/doi.org\/10.1111\/cen.13086","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,11]]}}}